First low resistance was low $120's so I put a portion of the BankLoad back in on the second dip in May and will ride this as I am playing just technicals on this now since I have no time for DD on it but haven't heard anything negatives. Could be hitting it's top....A forward split would be a nice reward for the longs though and that would get it moving again I would bet, ....
RSI still has a ton of head room after the cool off and MFI looks like more is flowing into this beast....Could see $200 before it hits the high water mark again....
Ya never retire from da game
Found it while I was playing GNTA (Genta) as that was channeling nicely for over a year...nice ATM there back then...lol....
I have 2 little ones so I let my IHub script run out last year and am just trying to get back into swing here again....A sell trigger going off on Jazz will do that to one...
Just checked out the board after I ran across this old post of mine....I have to be premium again to do searches, even on my own posts....lol...
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=59793209
My Tax Accountant better be worth his weight in gold this year...lolzzzzzzzzzzzzzz.... Weeeeeeeeeeeeeeeeeeeeeeeeeeeeeee.....
Have a good one!
Recent JAZZ News
- Jazz Pharmaceuticals Presents Updated Phase 2 Data for Zanidatamab Demonstrating Increased mPFS in HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ESMO 2024 • PR Newswire (US) • 09/16/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/11/2024 03:38:33 PM
- Jazz Pharmaceuticals to Present Advancements in Solid Tumor Oncology Research at ESMO 2024 • PR Newswire (US) • 09/09/2024 11:58:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 08:09:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/05/2024 11:50:34 PM
- Jazz Pharmaceuticals to Present New Data Demonstrating Improved Epilepsy Outcomes with Epidiolex®/Epidyolex® (cannabidiol) at the European Epilepsy Congress 2024 • PR Newswire (US) • 09/05/2024 11:30:00 AM
- Jazz Pharmaceuticals Announces Pricing of Private Offering of $850 Million of 3.125% Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases • PR Newswire (US) • 09/04/2024 04:12:00 AM
- Jazz Pharmaceuticals Announces Pricing of Private Offering of $850 Million of 3.125% Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases • PR Newswire (US) • 09/04/2024 04:00:00 AM
- Jazz Pharmaceuticals Announces Private Offering of $850 Million of Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases • PR Newswire (US) • 09/03/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2024 06:27:01 PM
- Jazz Pharmaceuticals Provides Update on Cannabidiol Oral Solution Phase 3 Trial in Japan in Treatment-Resistant Epilepsies • PR Newswire (US) • 08/22/2024 08:05:00 PM
- Jazz Pharmaceuticals to Participate in Upcoming September Investor Conferences • PR Newswire (US) • 08/21/2024 08:15:00 PM
- Jazz Pharmaceuticals to Participate in Upcoming September Investor Conferences • PR Newswire (US) • 08/21/2024 08:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 10:45:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 10:42:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 10:42:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 10:40:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 10:40:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 10:39:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 10:39:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:53:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:52:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:50:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:48:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/06/2024 01:57:56 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM